This value for the mean number of tumors occurring in genetic carriers may be used to estimate the mutation rate for each mutation. The germinal and somatic rates for the first, and the somatic rate for the second, mutation, are approximately equal. The germinal mutation may arise in some instances from a delayed mutation.
The origin of cancer by a process that involves more than one discreet stage is supported by experimental, clinical, and epidemiological observations. These stages are, in turn, attributed by many investigators to somatic mutations. Ashley (1) has calculated that the common cancers are produced by a number of mutations that varies from 3-7, according Table 2 .
Some patients that inherit the gene for retinoblastoma are never affected, although they transmit the trait to offspring who may become affected. ported by Stallard (6) . The data clearly fall between m = 2 andrm = 3. This calculation permits another; namely, that of the probability that a mutant cell will develop into a tumor. If n is the total number of cells in the two retinae that have the potential for tumor formation, then m/n expresses the probability that a cell with the inherited mutation will develop into a tumor cell. The retinoblastoma is derived from a cell that generates both the inner neuroblastic layer (which gives rise to the ganglion and amacrine cells) and the outer neuroblastic layer (which gives rise to the bipolar, horizontal, and visual receptor cells). The order of magnitude of the number of retinoblasts is probably reflected by the order of magnitude of the number of ganglion cells, cells derived from the earlydifferentiated inner molecular layer. The number of ganglion cells has been estimated at 2 X 106 per retina, or 4 X 106 for two eyes (7) . Using this value as an approximation for n, we find that the probability (m/n) that a cell with the inherited mutation will develop into a tumor cell is 0.75 X 10-. Since a majority of hereditary cases occurs within the first 2 years of prenatal and postnatal life, the probability, expressed as a mutation rate per year at either member of an autosomal gene pair, would be one-fourth of this value, or approximately 2 X 10-7 per year. This estimates the rate of a second mutation in cells already abnormal as a result of an inherited mutation at another gene site. Unilateral cases that do not result from germinal mutations constitute 55-65% of the total cases. If these cases arise by mutations at the same sites as in the hereditary form, then what is the relation between the somatic and germinal mutation rates for the first mutation? Let the two rates for this first mutation be Jig (germinal) and A. (somatic), and the probability of the second event be m/n for both cases. Furthermore, let i be the total incidence of retinoblastoma, fh the fraction of the hereditary cases, fO, the fraction of nonheredi- the probability of the second event, m/n, from which fn.i = 2 us*n-m/n = 2 ,g.m, and n= f i/2m.
The relationship between mutation rates is therefore:
As/Mg = fn/fhA 1/ms. (1 -e m ).
An estimate of s is difficult, as it has become lower with therapeutic success. For purposes of this calculation, we assume a value of s = 0.5. Using this and values noted above for the other parameters, we calculate
It is apparent that the two mutation rates are of a similar order of magnitude. The incidence of retinoblastoma is approximately 5 X 10-, from which the germinal mutation rate, it, may be calcu- This rate is close to that of 6-7 X 10-calculated by Vogel (3) . In the nonhereditary form, the mutation rate is expressed per year, which, assuming a generation time of 25-30 years, yields an estimate of approximately 2 X 10-7per year.
Although the above data are incompatible with two independent mutational "second events", they do not constitute direct evidence that a single independent "event" of any kind is involved. If a second, single event is involved, the distribution of bilateral cases with time should be an exponential function, i.e., the fraction of the total cases that develops in a given period of time should be constant, as expressed in the relationship dS/dt = -kS, and In S = -kt, where S is the fraction of survivors not yet diagnosed at time t, and dS is the change in this fraction in the interval dt. As shown in Fig. 1 , this is indeed the case. By contrast, the fractional decrease in unilateral cases per unit time does not show this relationship (Fig. 1) . Although 15-20% of the unilateral cases should be of the hereditary type and so contaminate the data, the observations more nearly fit the anticipated two-mutation expression, In S = -kt2, derived by Burch (8) . That a difference in mean age at diagnosis exists between unilateral and bilateral cases has been noted previously. The respective mean ages at diagnosis for bilateral and unilateral cases have been reported in other series as 15 and 24 months (9) and 15 and 29 months (10) , and in the present series are 15 and 32 months.
The exponential decline in new hereditary cases with time reflects the occurrence of a second event at a constant rate in a declining population of embryonal cells. For the nonhereditary cases, this declining population of cells must experience two independently occurring events. New cases of both types occur only in childhood because the embryonal cells vanish.
The data presented here and in the literature are consistent with the hypothesis that at least one cancer, retinoblastoma, can be caused by two mutations, each of which occurs at a rate of the order of 2 X 10-7 per year. One of these mutations may be inherited as a result of a previous germinal mutation that occurs at about the same rate. Those patients that inherit one mutation develop tumors earlier than do those who develop the nonhereditary form of the disease; in a majority of cases those who inherit a mutation develop more than one tumor. On the other hand, the probability that an individual not inheriting a mutation would develop more than one tumor is vanishingly small, so that nonhereditary cases are invariably unifocal.
The two-mutation hypothesis is consistent with current thought on the mutational origin of cancer. Ashley (1) has reviewed two-hit and multiple-hit theories of carcinogenesis and concluded that the common cancers are produced by about 3-7 mutations. Interestingly, one of the lowest estimates was for brain tumors, which are, like retinoblastoma, derived from neural elements. Ashley suggests that the twostage hypothesis of initiation and promotion may still be correct, in that each stage may result from more than one mutation.
In the present series of 48 cases, three, all bilateral, are familial. In one case an affected father and his affected brother had unaffected parents. The same situation of affected sibs with unaffected parents exists for our other two cases. Such instances have been noted repeatedly in the past, the most dramatic report being that of Macklin (11) , who found not only four families resembling those in the present series, but also ten families with affected cases in more widely separated relationships. Occasionally an unaffected parent may actually have had a retinoblastoma that has undergone spontaneous regression, but this must happen very rarely (2) . On the other hand, if one attempts to attribute these occurrences to de- 
